BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31980473)

  • 1. Chronic intestinal pseudo-obstruction due to β2microglobulin-amyloidosis in a patient on high-flux haemodialysis.
    De Mulder P; Cokelaere K; Terryn W
    BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31980473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic intestinal pseudo-obstruction due to dialysis-related amyloid deposition in the propria muscularis in a hemodialysis patient.
    Kanai H; Kashiwagi M; Hirakata H; Nagashima A; Tada S; Yao T; Nakamoto M; Nakamura S; Fujishima M
    Clin Nephrol; 2000 May; 53(5):394-9. PubMed ID: 11305814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis-related amyloidosis: Is it still relevant?
    Kaneko S; Yamagata K
    Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal pseudo-obstruction due to dialysis amyloidosis.
    Shinoda T; Komatsu M; Aizawa T; Shirota T; Yamada T; Ehara T; Mizukami E
    Clin Nephrol; 1989 Dec; 32(6):284-9. PubMed ID: 2612073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysis-related Amyloidosis: Is It Gone or Should It Be?
    Labriola L; Jadoul M
    Semin Dial; 2017 May; 30(3):193-196. PubMed ID: 28264226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis and management of dialysis-related amyloid bone disease.
    Nangaku M; Miyata T; Kurokawa K
    Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
    Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
    J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis.
    Jimenez RE; Price DA; Pinkus GS; Owen WF; Lazarus JM; Kay J; Turner JR
    Am J Surg Pathol; 1998 Jun; 22(6):729-35. PubMed ID: 9630180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis.
    Kazama JJ; Maruyama H; Gejyo F
    Nephrol Dial Transplant; 2001; 16 Suppl 4():31-5. PubMed ID: 11402095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysis-related amyloidosis: late finding or hidden epidemic?
    Dember LM; Jaber BL
    Semin Dial; 2006; 19(2):105-9. PubMed ID: 16551286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tendon thickening in dialysis-related joint arthritis is due to amyloid deposits at the surface of the tendon.
    Sigaux J; Abdelkefi I; Bardin T; Laredo JD; Ea HK; UreñaTorres P; Cohen-Solal M
    Joint Bone Spine; 2019 Mar; 86(2):233-238. PubMed ID: 30243785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
    Miyata T; Inagi R; Kurokawa K
    Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal beta2microglobulin amyloidosis in hemodialysis patients: biochemical analysis of amyloid proteins in small formalin-fixed paraffin-embedded tissue specimens.
    Kaplan B; Martin BM; Livoff A; Yeremenko D; Livneh A; Cohen HI
    Mod Pathol; 2005 Dec; 18(12):1610-7. PubMed ID: 16258516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis-related amyloidosis: history and clinical manifestations.
    Danesh F; Ho LT
    Semin Dial; 2001; 14(2):80-5. PubMed ID: 11264771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleural involvement of dialysis-related amyloidosis.
    Suzuki M; Betsuyaku T; Kojima T; Saito H; Nishiura Y; Fukasawa Y; Nishimura M; Kawakami Y
    Intern Med; 2005 Jun; 44(6):628-31. PubMed ID: 16020894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-microglobulin and renal bone disease.
    Wada T; Miyata T; Sakai H; Kurokawa K
    Perit Dial Int; 1999; 19 Suppl 2():S413-6. PubMed ID: 10406556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal transplantation relieves the symptoms but does not reverse beta 2-microglobulin amyloidosis.
    Mourad G; Argilés A
    J Am Soc Nephrol; 1996 May; 7(5):798-804. PubMed ID: 8738817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cartilage biomarkers in hemodialysis patients and the effect of beta2-microglobulin on articular chondrocytes.
    Sunk IG; Demetriou D; Szendroedi J; Amoyo L; Raffetseder A; Hörl WH; Sunder-Plassmann G; Smolen JS; Bobacz K
    Osteoarthritis Cartilage; 2008 Nov; 16(11):1336-42. PubMed ID: 18457963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in understanding dialysis-related amyloidosis.
    Yamamoto S; Kazama JJ; Narita I; Naiki H; Gejyo F
    Bone; 2009 Jul; 45 Suppl 1():S39-42. PubMed ID: 19303954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal pseudo-obstruction and ischemia secondary to both beta 2-microglobulin and serum A amyloid deposition.
    Borczuk A; Mannion C; Dickson D; Alt E
    Mod Pathol; 1995 Jun; 8(5):577-82. PubMed ID: 7675780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.